Cargando…

Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists

PURPOSE OF REVIEW: We summarise the current development of autologous haematopoietic stem cell transplantation (AHSCT) in treating multiple sclerosis (MS) and discuss future directions for the general neurologist, transplant haematologist and oncologist. RECENT FINDINGS: AHSCT was initially performe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Joyutpal, Sharrack, Basil, Snowden, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Stem Cell Transplantation (R Maziarz, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510794/ https://www.ncbi.nlm.nih.gov/pubmed/30828772 http://dx.doi.org/10.1007/s11899-019-00505-z

Ejemplares similares

Impact of the Affordable Care Act on Stem Cell Transplantation
por: Farnia, Stephanie, et al.
Publicado: (2014)

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia; Current Evidence, and Improving Outcomes Going Forward
por: Leonard, Jessica T., et al.
Publicado: (2018)

Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime?
por: Sucheston-Campbell, Lara E., et al.
Publicado: (2015)

10 Years of Preparedness by the Radiation Injury Treatment Network
por: Case, Cullen
Publicado: (2017)

Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy
por: Hakki, Morgan
Publicado: (2020)

COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis
por: Lim, Yeong Jer, et al.
Publicado: (2022)

Stem cell transplantation
por: Schaap, Nicolaas
Publicado: (2019)

The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia
por: Kim, Dennis D. H., et al.
Publicado: (2022)

A systematic literature review of the clinical signs and symptoms of veno‐occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation in adults and children
por: Angus, James, et al.
Publicado: (2022)

Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience
por: Kass-Iliyya, Lewis, et al.
Publicado: (2020)

Identification of the minimum requirements for successful haematopoietic stem cell transplantation
por: Nishi, Katsuyuki, et al.
Publicado: (2021)

Autologous haematopoietic stem cell therapy for multiple sclerosis: a review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation
por: Ismail, Azza, et al.
Publicado: (2019)

Unmanipulated haploidentical transplantation for adult patients with hematological malignancies
por: Ruggeri, Annalisa, et al.
Publicado: (2019)

A critical assessment of dose effects of post‐thaw CD34 on autologous stem cell transplantation treatment of haematological malignancies
por: Duarte, Gustavo de Carvalho, et al.
Publicado: (2023)

Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis
por: Das, J, et al.
Publicado: (2021)

Haploidentical haematopoietic stem cell transplantation for thalassaemia major based on an FBCA conditioning regimen
por: Sun, Qixin, et al.
Publicado: (2018)

A Case of Multiple Sclerosis—Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature
por: Das, Joyutpal, et al.
Publicado: (2020)

The impact of pulmonary function in patients undergoing autologous stem cell transplantation
por: Duque-Afonso, Jesús, et al.
Publicado: (2021)

Oncologist’s/haematologist’s view on the roles of pathologists for molecular targeted cancer therapy
por: Keller, Ulrich, et al.
Publicado: (2010)

Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning
por: Townsend, William M, et al.
Publicado: (2013)

Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis
por: Roy, Denis Claude, et al.
Publicado: (2019)

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma
por: Herrera, Alex F., et al.
Publicado: (2021)

Interest of the preventive and curative use of defibrotide on the occurrence and severity of sinusoidal obstruction syndrome after hematopoietic stem cell transplant in children
por: Rudebeck, Carl J., et al.
Publicado: (2022)

Global longitudinal strain is superior to ejection fraction for long‐term follow‐up after allogeneic hematopoietic stem cell transplantation
por: Watanabe, Marika, et al.
Publicado: (2022)

Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia
por: Ichikawa, Hiroya, et al.
Publicado: (2023)

Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation
por: Kaloyannidis, Panayotis, et al.
Publicado: (2019)

Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis
por: Ragon, Brittany Knick, et al.
Publicado: (2023)

Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage‐specific chimerism analysis
por: Lindahl, Hannes, et al.
Publicado: (2022)

Pooled analysis of Day 100 survival for defibrotide‐treated patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation
por: Richardson, Paul G., et al.
Publicado: (2020)

How views of oncologists and haematologists impacts palliative care referral: a systematic review
por: Salins, Naveen, et al.
Publicado: (2020)

Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers
por: Circosta, Paola, et al.
Publicado: (2022)

Diagnostic Testing of COVID-19 in Solid Organ Transplantation: Current Clinical Application and Future Strategies
por: Trubin, Paul A., et al.
Publicado: (2020)

Nomograms for Hæmatologists
por: Bell, George H.
Publicado: (1939)

Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
por: Guo, Wancheng, et al.
Publicado: (2023)

CD94 Ex Vivo Cultures in a Bone Marrow Transplantation Setting
por: Abrams, Kraig, et al.
Publicado: (2020)

Persistent Facial and Chest Papular and Pustular Eruption in a Stem Cell Transplant Patient
por: Keiser, Monika F., et al.
Publicado: (2021)

The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Willison, A. G., et al.
Publicado: (2022)

Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients
por: Gama, Bianca E., et al.
Publicado: (2017)

ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients
por: Kim, Min Young, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l820st8ia392pudt4o49em3fqe